Interdigitating Dendritic Cell Sarcoma
1 clinical trials · Condition
◉ Watch Interdigitating Dendritic Cell Sarcoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Neoplasms or Lymphomas (NCT03316573) | Dana-Farber Cancer Institute | 2017-12-07 |
Track Interdigitating Dendritic Cell Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.